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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A384expression level. On the other hand, 10 mM of DEX signiﬁcantly further
increased upregulated ADAMTS-4 gene expression by biomechanical
stimulation. Inhibition of MyD88 by IL-1Ra suppressed PGE2 pro-
duction at least partially in biomechanical stimulation and IL-1b
stimulation.
Conclusions: NSAIDs, DEX and MyD88 inhibition by IL-Ra suppressed
biomechanically or biochemically upregulated PGE2 production,
whereas IL-6 production was unchanged in NSAIDs, indicating the
possibility that mechanical stress could utilizes at least partially the IL-1
receptor signal transduction in the process of PGE2 production. Sup-
pression of ADAMTS-4 by CEL and relatively high dose of IND indicated
that these NSAIDs may have chondroprotective effect, while DEX which
further increased ADAMTS-4 gene expression after biomechanical
stimulation may imply the destructive effect of DEX by biomechanically
affected synovial joint.Therapy: Non-Pharmacologic
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Purpose: To investigate the efﬁcacy of low-level laser therapy (LLLT)
treatment of knee osteoarthritis (KOA) by carrying out a systematic
literature search followed by meta-analyses on selected studies.
Methods: MEDLINE, EMBASE, ISI Web of Science and Cochrane
Library databases were systematically searched from January 2000 to
November 2014. Studies were included if they were randomized
controlled trials (RCTs) , written in English, comparing LLLT with
sham laser in KOA patients diagnosed according to American College
of Rheumatology guidelines. Two independent reviewers assessed
study quality using the PEDro scale. Meta-analyses were performed
to get an indication of treatment efﬁcacy from the available pooled
data.Table 1. General Information of Recruited Studies
Study Type of
studies
No.
Sample Size Age (y) Gender
(M/F)
BMI
Gur et al. 2003 DB-RCT Study Group (n¼30) 58.64 (5.92) 5/25 31.1
Control Group (n¼30) 60.52 (6.91) 6/24 30.2
Tascioglu et al. 2004 DB-RCT Study Group (n¼20) 62.86 (7.32) 6/14 27.5
Control Group (n¼20) 64.27 (10.55) 7/13 29.5
Yurtkuran et al. 2007 DB-RCT Study Group (n¼28) 51.83 (6.83) 1/27 31.7
Control Group (n¼27) 53.478 (7.13) 1/26 32.7
Alfredo et al. 2011 DB-RCT Study Group (n¼24) 61.15 (7.52) 5/15 30.1
Control Group (n¼22) 62.25 (6.87) 4/16 29.2
Fukuda et al. 2011 DB-RCT Study Group (n¼25) 63.0 (9.0) 5/20 30.0
Control Group (n¼22) 63.0 (8.0) 8/14 28.7
Alghadir et al. 2014 SB-RCT Study Group (n¼20) 55.2 (8.14) 10/10 32.3
Control Group (n¼20) 57 (7.77) 12/8 33.0
Kheshie et al. 2014 SB-RCT Study Group (n¼20) 56.56 (7.86) 20/0 28.6
Control Group (n¼20) 55.6(11.02) 20/0 28.5
Al Rashoud et al. 2014 DB-RCT Study Group (n¼26) 52 (9) 10/16 38.0
Control Group (n¼23) 56(11) 8/15 37.1
Hinman et al. 2014 DB-RCT Study Group (n¼71) 63.4(8.7) 43/28 30.7
Control Group (n¼70) 63.8 (7.5) 31/39 28.8
DB-RCT: Double blind-randomized controlled trial; SB-RCT: Single blind-randomized co
Mean (standard deviation) are provided above for age, BMI, pain and function
a N: Not conforming to WALT recommendations
b Y: Conforming to WALT recommendationsResults: Nine randomized controlled trials (7 double-blind, 2 single-
blind) met the criteria for inclusion (Table 1). Data of 518 patients were
extracted (264 patients in treated groups, 254 patients in control
groups, 58% female, mean age ranging from 51.83 to 64.27 years,
Kellgren-Lawrence grade2). The methodological quality of all inclu-
ded studies was high based on a PEDro score7. Seven trials provided
data on pain assessed by VAS scale right after therapy. The standardized
mean difference (SMD) in VAS pain score right after therapy was not
signiﬁcantly different between treated and control groups (SMD¼-0.28
[95% CI¼-0.66, 0.10], I-square¼66%)(Figure 1). Subgroup analysis based
on whether the studies were performed according to the World Asso-
ciation Laser Therapy (WALT) recommendations also failed to unmask
any signiﬁcant difference by laser treatment status (Figure 1). Moreover,
another subgroup analysis based on the severity of OA also did not
identify any signiﬁcant differences between the two groups (SMD -0.28,
95%CI -0.66, 0.10). Analysis of the pooled data from the ﬁve studies with
VAS pain data after 12 weeks of therapy also did not support the
superiority of LLLT over placebo at this timepoint. Similar results were
obtained when we analyzed the pooled data on WOMAC pain, stiffness
and function outcomes (5 and 3 studies had outcome data right after
and 12 weeks after therapy respectively).
Conclusions: Our ﬁndings indicate that the best available current evi-
dence, based on studies with sham laser control therapy, does not
support the effectiveness of using LLLT as a therapy for patients with
KOA.Clinical Baseline PEDro
score
WALT
Recommendations
Dropouts Pain Function
7(3.77) 0 73.2 (23.7) 54.56(13.37) 9 Na
7 (3.11) 0 67.4(17.3) 50.76 (15.42)
6 (5.65) 0 68.0 (15.45) 36.60 (7.09) 9 Yb
6 (9.54) 0 63.88 (16.07) 39.46 (12.56)
6 (8.81) 1 64.7(16.1) 47.53 (12.85) 9 Na
2 (3.71) 2 60.6(21.7) 35.31 (13.75)
6(4.12) 4 53.2 (35.5) 33.85 (16.93) 8 Yb
1 (4.95) 2 35.4 (30.6) 27.15 (11.32)
(3.5) 0 61 (26) / 9 Yb
(4.1) 0 61 (23)
4 (5.77) 0 74.5 (10.5) 25.95 (9.23) 8 Yb
9 (4.98) 0 75.5(13.5) 30.7 (11.03)
2 (5.20) 2 76.8 (6.58) 30.44 (3.66) 7 Na
1 (3.35) 5 78.7(3.51) 31.00 (3.42)
(5.6) 0 64(19) 61 (44-71) 9 Na
(5.3) 0 59(18) 60 (49-70)
(6.1) 13 49 (19) 27.0(11.3) 8 Na
(5.4) 19 50 (21) 27.5 (12.4)
ntrolled trial; BMI: Body mass index.
